Email this page
Print this page
a a a
Master's programmes

Infection and Immunity

Infection and Immunity studies molecular, cellular and clinical aspects of pathogens and immune responses.

Infectious diseases and immunity disorders are a continuous threat to human and animal life and well-being. The objective of the institutes offering the Immunity and Infection Master’s programme is to improve the prevention, diagnosis and treatment of infectious diseases and immunity disorders by performing basic and clinical research with a multidisciplinary approach. Challenges facing researchers in this field include e.g. new pathogens such as the virus causing SARS, a new disease that has had a considerable impact on society.

This Master’s programme aims to give young scientists the opportunity to gain profound knowledge of fundamental and clinical immunology, vaccination strategies, immunotherapy in the context of cancer, the mechanisms of infectious diseases, the molecular epidemiology of infections, virulence factors of micro-organisms and resistance to therapy. Students will be required to undertake a major and a minor research project, as well as writing a Master’s thesis and giving presentations about their own work and that of others. In addition, students will follow theoretical courses and seminars, and take part in master classes given by eminent scientists.

NVAO 

NVAO accredited programme

This Master’s programme has been accredited by the Accreditation Organisation of the Netherlands and Flanders (NVAO).
Find out more about the NVAO


Interested in this course?
>> Find out more
Research programme Language: English Type of education: full-time
Start: September; February Duration: 2 years (120 ECTS) Degree: MSc
Statutory tuition fee: 1,771 euro (2012-2013) Scholarship: No
.
Institutional tuition fee: 17,900 euro (2012-2013)
Read more about tuition fees.
Offered by: Graduate School of Life Sciences; Faculty of Medicine
This Master's programme is officially registered under the name Biomedical Sciences (code 66990).